According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

Old Town Med Spa is among those being accused of using false advertising and deceptive marketing practices to sell ...

Amgen's latest once-monthly weight loss drug data looks "OK," analysts say, as its path to approval still remains murky.

Walmart is rolling back diversity policies, the Biden Administration is proposing Medicare and Medicaid cover obesity ...

Semaglutide being investigated for applications in heart disease, Alzheimer's, liver disease, and moreGLP-1 drugs expected to generate multi-hundreds of billions of revenues in the years to come ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly blockbuster GLP-1 drugs Zepbound and Mounjaro are in shortage. Shares of the ...

France said Wednesday that it 'intends to continue to work in close collaboration' with Israeli Prime Minister Benjamin Netanyahu despite an arrest warrant issued for him by the world’s top war crimes ...

CMS proposes changes to Medicare and Medicaid to cover weight-loss drugs, recognizing obesity as a disease. This could expand ...

There have been 274 hospitalisations associated with weight-loss injections - far higher than the 68 previously detailed by ...

Donna Luger was diagnosed with Lyme disease twelve years ago. She recalls the experience as being a constant battle with ...

President-elect Donald Trump’s proposed lineup to lead the government’s health agencies look like bad news for vaccine ...

The new PenCycle programme covers Novo Nordisk's FlexPen and FlexTouch devices ... are too good to waste," according to the scheme's website. "By recycling them, we can help to give these ...